Molecular prognostic factors in bladder cancer
- 24 March 2005
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 95 (6) , 739-742
- https://doi.org/10.1111/j.1464-410x.2005.05393.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesisOncogene, 2004
- Current understanding of the biology of advanced bladder cancerCancer, 2003
- OVER EXPRESSION OF CD44V8-10 IN URINARY EXFOLIATED CELLS AS AN INDEPENDENT PROGNOSTIC PREDICTOR IN PATIENTS WITH UROTHELIAL CANCERJournal of Urology, 2002
- The Hallmarks of CancerCell, 2000
- Loss of Cell Cycle Regulators p27Kip1 and Cyclin E in Transitional Cell Carcinoma of the Bladder Correlates with Tumor Grade and Patient SurvivalThe American Journal of Pathology, 1999
- URINARY VASCULAR ENDOTHELIAL GROWTH FACTOR AND ITS CORRELATION WITH BLADDER CANCER RECURRENCE RATESJournal of Urology, 1999
- Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicityOncogene, 1997
- Angiogenesis in Bladder Cancer: Relationship Between Microvessel Density and Tumor PrognosisJNCI Journal of the National Cancer Institute, 1995
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- The Product of the Human c- erb B-2 Gene: a 185-Kilodalton Glycoprotein with Tyrosine Kinase ActivityScience, 1986